These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38478092)

  • 1. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.
    Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M
    World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.
    Viers BR; Lieske JC; Vrtiska TJ; Herrera Hernandez LP; Vaughan LE; Mehta RA; Bergstralh EJ; Rule AD; Holmes DR; Krambeck AE
    Urology; 2015 Apr; 85(4):771-6. PubMed ID: 25681832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Metabolic Correlates of Pure Stone Subtypes.
    Brinkman JE; Large T; Nottingham CU; Stoughton C; Krambeck AE
    J Endourol; 2021 Oct; 35(10):1555-1562. PubMed ID: 33573466
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic syndrome and the risk of calcium stones.
    Sakhaee K; Capolongo G; Maalouf NM; Pasch A; Moe OW; Poindexter J; Adams-Huet B
    Nephrol Dial Transplant; 2012 Aug; 27(8):3201-9. PubMed ID: 22247230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urine uric acid level may have different predictive value for urinary stone composition: a retrospective cohort study of 718 patients in Chinese population.
    Wen W; Li Y; Chen Q; Li J
    Int Urol Nephrol; 2022 Sep; 54(9):2247-2254. PubMed ID: 35089471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Nomogram for Prediction of the Uric Acid Composition of Ureteral Stones as a Part of Tailored Stone Therapy.
    Wiessmeyer JR; Ozimek T; Struck JP; Hupe MC; Willig J; Merseburger AS; Kramer MW
    Eur Urol Focus; 2022 Jan; 8(1):291-296. PubMed ID: 33589393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between patients' kidney stone type and demographics in Israel: analysis of 10 K patients.
    Zreik R; Pilosov Solomon I; Saliba W; Tor R; Cohen S; Friefeld Y; Dekel Y; Klein I
    World J Urol; 2023 Jun; 41(6):1641-1646. PubMed ID: 37184690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stone characteristics on noncontrast computed tomography: establishing definitive patterns to discriminate calcium and uric acid compositions.
    Marchini GS; Remer EM; Gebreselassie S; Liu X; Pynadath C; Snyder G; Monga M
    Urology; 2013 Sep; 82(3):539-46. PubMed ID: 23987148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple dietary advice targeting five urinary parameters reduces urinary supersaturation in idiopathic calcium oxalate stone formers.
    Sromicki J; Hess B
    Urolithiasis; 2020 Oct; 48(5):425-433. PubMed ID: 32524204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.